OBJECTIVES: Overweight/obesity is known to increase the risk of developing renal cell carcinoma (RCC). However, data on the prognostic impact of overweight in RCC is still conflicting. We assessed whether different body mass index (BMI) levels at the time of surgery had an effect on the long-term prognosis of RCC patients. METHODS: We evaluated 771 patients, with complete information about their BMI, who had undergone renal surgery for RCC between 1990 and 2005 at the authors' institution; the mean follow-up was 5.48 years. RESULTS: Underweight, normal weight, pre-obesity, and obesity were diagnosed in 4 (0.5%), 239 (31%), 356 (46.2%), and 172 (22.3%) RCC patients, respectively. Overweight (BMI >25) was significantly associated with younger age (P = 0.004) and positive nodal status (P = 0.04) but not with tumor stage, grade, visceral metastasis, gender, histological subtype, or tumor-related symptoms. Overweight patients had a significantly lower risk of cancer-related death; their median 5-year tumor-specific survival rate was 80% as opposed to 72% for patients with a BMI below 25 (P = 0.003). Interestingly, subgroup analysis revealed that the positive association between overweight and survival was even more pronounced in organ-confined (P < 0.001) RCC, but no correlation was observed in advanced disease (P = 0.23). CONCLUSION: We were able to identify overweight as an independent prognostic marker of improved tumor-specific survival in patients with organ-confined RCC. Basic research is required to resolve the dilemma of why, if a higher BMI predisposes to RCC, it concurrently prolongs survival after patients have undergone (partial) nephrectomy.
OBJECTIVES: Overweight/obesity is known to increase the risk of developing renal cell carcinoma (RCC). However, data on the prognostic impact of overweight in RCC is still conflicting. We assessed whether different body mass index (BMI) levels at the time of surgery had an effect on the long-term prognosis of RCCpatients. METHODS: We evaluated 771 patients, with complete information about their BMI, who had undergone renal surgery for RCC between 1990 and 2005 at the authors' institution; the mean follow-up was 5.48 years. RESULTS: Underweight, normal weight, pre-obesity, and obesity were diagnosed in 4 (0.5%), 239 (31%), 356 (46.2%), and 172 (22.3%) RCCpatients, respectively. Overweight (BMI >25) was significantly associated with younger age (P = 0.004) and positive nodal status (P = 0.04) but not with tumor stage, grade, visceral metastasis, gender, histological subtype, or tumor-related symptoms. Overweight patients had a significantly lower risk of cancer-related death; their median 5-year tumor-specific survival rate was 80% as opposed to 72% for patients with a BMI below 25 (P = 0.003). Interestingly, subgroup analysis revealed that the positive association between overweight and survival was even more pronounced in organ-confined (P < 0.001) RCC, but no correlation was observed in advanced disease (P = 0.23). CONCLUSION: We were able to identify overweight as an independent prognostic marker of improved tumor-specific survival in patients with organ-confined RCC. Basic research is required to resolve the dilemma of why, if a higher BMI predisposes to RCC, it concurrently prolongs survival after patients have undergone (partial) nephrectomy.
Authors: S Störkel; J N Eble; K Adlakha; M Amin; M L Blute; D G Bostwick; M Darson; B Delahunt; K Iczkowski Journal: Cancer Date: 1997-09-01 Impact factor: 6.860
Authors: Alexander S Parker; Christine M Lohse; John C Cheville; David D Thiel; Bradley C Leibovich; Michael L Blute Journal: Urology Date: 2006-10 Impact factor: 2.649
Authors: Ashish M Kamat; Ryan P Shock; Yoshio Naya; Charles J Rosser; Joel W Slaton; Louis L Pisters Journal: Urology Date: 2004-01 Impact factor: 2.649
Authors: Axel Haferkamp; Maria Pritsch; Jens Bedke; Nina Wagener; Jesco Pfitzenmaier; Stephan Buse; Markus Hohenfellner Journal: BJU Int Date: 2008-02-05 Impact factor: 5.588
Authors: Christian Eichelberg; Sarah Minner; Hendrik Isbarn; Eike Burandt; Luigi Terracciano; Holger Moch; Alexandra Kell; Roman Heuer; Felix K Chun; Guido Sauter; Margit Fisch; Pierre Tennstedt Journal: World J Urol Date: 2011-10-19 Impact factor: 4.226
Authors: Madhur Nayan; Robert J Hamilton; Antonio Finelli; Peter C Austin; Girish S Kulkarni; David N Juurlink Journal: Can Urol Assoc J Date: 2017-06 Impact factor: 1.862
Authors: S Waalkes; H Eggers; J Rustemeier; G Wegener; F Jentzmik; M Schrader; R Hofmann; M A Kuczyk; A J Schrader Journal: Urologe A Date: 2011-09 Impact factor: 0.639
Authors: Amit K Mathur; Amir A Ghaferi; Kristen Sell; Christopher J Sonnenday; Michael J Englesbe; Theodore H Welling Journal: J Gastrointest Surg Date: 2010-02-06 Impact factor: 3.452
Authors: Marcovalerio Melis; Jill M Weber; James M McLoughlin; Erin M Siegel; Sarah Hoffe; Ravi Shridhar; Kiran K Turaga; George Dittrick; E Michelle Dean; Richard C Karl; Kenneth L Meredith Journal: Ann Surg Oncol Date: 2010-09-24 Impact factor: 5.344
Authors: Sandra Steffens; Viktor Grünwald; Kristina I Ringe; Christoph Seidel; Hendrik Eggers; Mark Schrader; Frank Wacker; Markus A Kuczyk; Andres J Schrader Journal: Oncologist Date: 2011-10-21
Authors: Sandra Waalkes; Faranaz Atschekzei; Mario W Kramer; Jörg Hennenlotter; Gesa Vetter; Jan U Becker; Arnulf Stenzl; Axel S Merseburger; Andres J Schrader; Markus A Kuczyk; Jürgen Serth Journal: BMC Cancer Date: 2010-09-22 Impact factor: 4.430
Authors: Bumsoo Park; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Han Yong Choi; Hyun Moo Lee Journal: J Korean Med Sci Date: 2013-01-29 Impact factor: 2.153